Abiy Habtewolde Eyakem
Abiy Habtewolde Eyakem
School of Pharmacy, William Carey University
Verified email at wmcarey.edu
Cited by
Cited by
Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africaá…
E Ngaimisi, A Habtewold, O Minzi, E Makonnen, S Mugusi, W Amogne, ...
PloS one 8 (7), e67946, 2013
Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients
G Yimer, N Ueda, A Habtewold, W Amogne, A Suda, KD Riedel, ...
PLoS One 6 (12), e27810, 2011
High plasma efavirenz level and CYP2B6* 6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naive HIV patients from Ethiopia: a prospectiveá…
G Yimer, W Amogne, A Habtewold, E Makonnen, N Ueda, A Suda, ...
The pharmacogenomics journal 12 (6), 499-506, 2012
Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients
A Habtewold, W Amogne, E Makonnen, G Yimer, KD Riedel, N Ueda, ...
Journal of antimicrobial chemotherapy 66 (10), 2350-2361, 2011
Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients
G Yimer, M Gry, W Amogne, E Makonnen, A Habtewold, Z Petros, ...
PLoS One 9 (4), e94271, 2014
β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans
RJ Hardwick, W Amogne, S Mugusi, G Yimer, E Ngaimisi, A Habtewold, ...
The Journal of infectious diseases 206 (7), 1012-1019, 2012
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients
A Habtewold, W Amogne, E Makonnen, G Yimer, H Nylen, KD Riedel, ...
The pharmacogenomics journal 13 (6), 484-489, 2013
CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans
E Aklillu, L Odenthal-Hesse, J Bowdrey, A Habtewold, E Ngaimisi, ...
BMC infectious diseases 13 (1), 1-10, 2013
Efficacy and safety of antiretroviral therapy initiated one week after tuberculosis therapy in patients with CD4 counts< 200 cells/μL: TB-HAART study, a randomized clinical trial
W Amogne, G Aderaye, A Habtewold, G Yimer, E Makonnen, A Worku, ...
PLoS One 10 (5), e0122587, 2015
HLA-B* 57 allele is associated with concomitant anti-tuberculosis and antiretroviral drugs induced liver toxicity in Ethiopians
Z Petros, J Kishikawa, E Makonnen, G Yimer, A Habtewold, E Aklillu
Frontiers in pharmacology 8, 90, 2017
Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study
A Habtewold, E Makonnen, W Amogne, G Yimer, G Aderaye, L Bertilsson, ...
Pharmacogenomics 16 (10), 1047-1064, 2015
Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients
SM Abay, M Tilahun, N Fikrie, A Habtewold
The Journal of Infection in Developing Countries 7 (06), 468-474, 2013
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
Z Petros, MTM Lee, A Takahashi, Y Zhang, G Yimer, A Habtewold, ...
BMC genomics 17 (1), 1-8, 2016
SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine
E Aklillu, A Habtewold, E Ngaimisi, G Yimer, S Mugusi, W Amogne, ...
Omics: a journal of integrative biology 20 (9), 538-545, 2016
Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa
LR Machado, J Bowdrey, E Ngaimisi, A Habtewold, O Minzi, E Makonnen, ...
PloS one 8 (11), e78165, 2013
T follicular helper cells and antibody response to Hepatitis B virus vaccine in HIV-1 infected children receiving ART.
CF Bekele Y, Yibeltal D, Bobosha K, Andargie TE, Lemma M, Gebre M, Mekonnen ...
Sci Rep. 7 (1), 8956, 2017
Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency: A prospective cohort study
H NylÚn, A Habtewold, E Makonnen, G Yimer, L Bertilsson, J Burhenne, ...
Medicine 95 (34), 2016
Genome-wide association and replication study of hepatotoxicity induced by antiretrovirals alone or with concomitant anti-tuberculosis drugs
Z Petros, MTM Lee, A Takahashi, Y Zhang, G Yimer, A Habtewold, ...
Omics: a journal of integrative biology 21 (4), 207-216, 2017
Long‐term effect of rifampicin‐based anti‐TB regimen coadministration on the pharmacokinetic parameters of efavirenz and 8‐hydroxy‐efavirenz in Ethiopian patients
A Habtewold, E Aklillu, E Makonnen, W Amogne, G Yimer, G Aderaye, ...
The Journal of Clinical Pharmacology 56 (12), 1538-1549, 2016
Population Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients
A Habtewold, E Aklillu, E Makonnen, G Yimer, L Bertilsson, J Burhenne, ...
Antimicrobial agents and chemotherapy 61 (8), e00207-17, 2017
The system can't perform the operation now. Try again later.
Articles 1–20